By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Incyte Corporation 

Experimental Station
Route 141 & Henry Clay Road, Building E336
Wilmington  Delaware  19880  U.S.A.
Phone: 302-498-6700 Fax: 302-425-2750


Company News
Incyte (INCY) Named 7th Most Innovative Company In The World By Forbes Magazine 8/21/2015 9:55:56 AM
Incyte (INCY) Reports 2015 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 8/4/2015 10:37:07 AM
Incyte (INCY) To Report Second Quarter Financial Results On August 4 7/14/2015 11:44:37 AM
Incyte (INCY) And Vanderbilt University Medical Center Establish Multi-Year Oncology Research Alliance 7/7/2015 10:24:39 AM
Incyte (INCY) Reorganizes and Shakes Up Management to Drive Growth 6/19/2015 7:36:11 AM
Eli Lilly (LLY) And Incyte Incyte (INCY) Detailed Data On Two Pivotal Studies Of baricitinib In Rheumatoid Arthritis 6/10/2015 6:58:06 AM
Advaxis, Inc. Announces FDA Clearance Of Investigational New Drug Application For Phase 2 Study Of ADXS-HPV And Incyte (INCY)'s Epacadostat For The Treatment Of HPV-Associated Early Stage Cervical Cancer 6/1/2015 6:38:13 AM
Eli Lilly (LLY) And Incyte (INCY) Announce Webcast To Discuss Baricitinib Phase III Data 5/29/2015 6:58:18 AM
Incyte (INCY) Clinical Portfolio To Be Featured In 23 Abstract Presentations At The 2015 ASCO And European Hematology Association Annual Meetings 5/27/2015 11:22:00 AM
Incyte (INCY) Reports 2015 First-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 4/30/2015 12:32:40 PM